Renewable Design for Rapid Testing Nasal Swab - KaiBiLi COVID-19 Antigen – Genesis
Renewable Design for Rapid Testing Nasal Swab - KaiBiLi COVID-19 Antigen – Genesis Detail:
Introduction
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.
This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE).
Detection
The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.
Specimen
Nasal or nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 140 TCID50/mL
ACCURACY (Nasal swab)
Positive Percent Agreement: 96.6%
Negative Percent Agreement:100%
Overall Percent Agreement: 98.9%
ACCURACY(Nasopharyngeal swab)
Positive Percent Agreement: 97.0%
Negative Percent Agreement:98.3%
Overall Percent Agreement: 97.7%
Time to Results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
Description |
Qty |
COVID-19 antigen test devices |
20 |
Sterilized swabs |
20 |
Extraction tubes (with 0.5mL extraction buffer) |
20 |
Nozzles with filter |
20 |
Tube Stand |
1 |
Package Insert |
1 |
Ordering Information
Product |
Cat.No. |
Contents |
KaiBiLiTM COVID-19 Antigen |
P211139 |
20 Tests |
Product detail pictures:
Related Product Guide:
We're convinced that with joint endeavours, the business between us will bring us mutual benefits. We are able to guarantee you products high quality and competitive value for Renewable Design for Rapid Testing Nasal Swab - KaiBiLi COVID-19 Antigen – Genesis , The product will supply to all over the world, such as: Singapore, Belgium, Angola, We have more than 200 staff including experienced managers, creative designers, sophisticated engineers and skilled workers. Through hard work of all employees for the past 20 years own company grew stronger and stronger. We always apply the "client first" principle. We also always fulfill all contracts to the point and therefore enjoy excellent reputation and trust among our customers. You are very welcome to personally visit our company.We hope to start a business partnership on the basis of mutual benefit and successful development . For more information please do no hesitate to contact us..
By Coral from Bulgaria - 2018.12.30 10:21
The supplier cooperation attitude is very good, encountered various problems, always willing to cooperate with us, to us as the real God.
By Ada from Uzbekistan - 2018.11.06 10:04